retatrutide clinical trial parkinson Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP, Top Dystonia Clinical Trials |

One in eight patients on retatrutide reported complete freedom from knee pain

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

100 mg de t verde (95% polifenoles, 80% catequinas, 50% EGCG y 1% cafena)

June 8 (Reuters) - Use of GLP-1 drugs for diabetes or obesity early in the first trimester of pregnancy, before a woman realizes she is pregnant, is not a cause for alarm, a large new data analysis suggests

Muscle cramps affect some patients taking semaglutide for weight loss

GLP-1 has proven its mettle as a well-tolerated, highly effective and sustainable weight loss injection, but many still misunderstand how it works.